UnitedHealth said on Thursday it will replace its finance chief John Rex with an external hire, Wayne DeVeydt, adding to the ...

UnitedHealth (UNH) stock continues the recent downtrend as the company faces a downgrade from Baird due to a challenging path ...

UnitedHealth is a beaten-down healthcare giant that trades at a lower valuation right now. Is UNH stock a good buy today?

UnitedHealth Group, America’s largest health care company, shocked investors Tuesday by reporting unexpectedly awful ...

With UnitedHealth’s weak Q2 results, the reset in 2025 guidance and earnings expectations brings clarity, but headwinds seem ...

UnitedHealth Group said on Thursday it will replace its finance chief John Rex with an external hire, Wayne DeVeydt, adding to the management changes at the health insurer that has been struggling to ...

UnitedHealth Group is also moving forward with cost-cutting initiatives to boost its bottom line. CEO Stephen Hemsley ...

The federal Equal Employment Opportunity Commission sued Mayo after it denied a security guard’s bid for exemption from COVID ...

UnitedHealth Group Inc. (NYSE: UNH) shares are trading lower Thursday, after Baird downgraded the stock to Underperform and slashed its price target from $312 to $198.

The insurance company has now added cancer diagnostic tests for colorectal and breast cancer to their benefit offering.

Dragged down by losses for shares of UnitedHealth and Merck, the Dow Jones Industrial Average is falling Thursday afternoon.

Behind losses for shares of UnitedHealth and Merck, the Dow Jones Industrial Average is declining Thursday afternoon.